Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Fisher

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Pediatric Quality & Safety|September 20, 2018
Moving the Needle in Children's Health with National Collaborative Networks-A CEO's PerspectiveMichael Fisher
The Clinical Teacher|July 24, 2023
Reflections on age, ageing and ageismJames Michael Fisher
International Journal of Cardiology|June 8, 2006
Too young to dieSebastian Benaya, Michael Fisher
Pharmacology & Therapeutics|June 16, 2010
Therapeutic advances in myocardial microvascular resistance: unravelling the enigmaBillal Patel, Michael Fisher
Postgraduate Medical Journal|June 1, 2012
Takotsubo cardiomyopathy: pathophysiology and treatmentKristijonas Milinis, Michael Fisher
The Journal of Family Practice|April 30, 2002
Clinical inquiries. Is prostate-specific antigen (PSA) screening indicated for any subgroup of men?Michael Fisher, Ellen Beck
Health & Social Work|May 31, 2003
Twelve-step recovery and community serviceLinda Farris Kurtz, Michael Fisher
The Journal of the Acoustical Society of America|July 24, 2008
Active cancellation of occlusion: an electronic vent for hearing aids and hearing protectorsJorge Mejia, Harvey Dillon, Michael Fisher
Cardiology|April 29, 2010
First report of the successful use of bosentan in refractory vasospastic anginaUnni Krishnan, Wutyee Win, Michael Fisher
Cardiovascular Research|May 29, 2002
Down-regulation of the ERK1 and ERK2 mitogen-activated protein kinases using antisense oligonucleotides inhibits intimal hyperplasia in a porcine model of coronary balloon angioplastyBo Liu, Michael Fisher, Peter Groves
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Pediatric Quality & Safety|September 20, 2018
Moving the Needle in Children's Health with National Collaborative Networks-A CEO's PerspectiveMichael Fisher
The Clinical Teacher|July 24, 2023
Reflections on age, ageing and ageismJames Michael Fisher
International Journal of Cardiology|June 8, 2006
Too young to dieSebastian Benaya, Michael Fisher
Pharmacology & Therapeutics|June 16, 2010
Therapeutic advances in myocardial microvascular resistance: unravelling the enigmaBillal Patel, Michael Fisher
Postgraduate Medical Journal|June 1, 2012
Takotsubo cardiomyopathy: pathophysiology and treatmentKristijonas Milinis, Michael Fisher
The Journal of Family Practice|April 30, 2002
Clinical inquiries. Is prostate-specific antigen (PSA) screening indicated for any subgroup of men?Michael Fisher, Ellen Beck
Health & Social Work|May 31, 2003
Twelve-step recovery and community serviceLinda Farris Kurtz, Michael Fisher
The Journal of the Acoustical Society of America|July 24, 2008
Active cancellation of occlusion: an electronic vent for hearing aids and hearing protectorsJorge Mejia, Harvey Dillon, Michael Fisher
Cardiology|April 29, 2010
First report of the successful use of bosentan in refractory vasospastic anginaUnni Krishnan, Wutyee Win, Michael Fisher
Cardiovascular Research|May 29, 2002
Down-regulation of the ERK1 and ERK2 mitogen-activated protein kinases using antisense oligonucleotides inhibits intimal hyperplasia in a porcine model of coronary balloon angioplastyBo Liu, Michael Fisher, Peter Groves
Pageof 15